Botanix Pharmaceuticals’ Post

View organization page for Botanix Pharmaceuticals, graphic

3,223 followers

"Compelling Opportunity” | E&P Research Report   In new research on Botanix, leading biotech analyst David Nayagam from E&P highlights the “compelling opportunity” that the Company presents and initiates coverage with a speculative buy and $0.55 price target. View E&P Report 👉 https://bit.ly/BOT-EP-Note   $BOT #ASX #dermatology #pharmaceuticals #pharma #biotech #innovation #hyperhidrosis #launch

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics